Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Saro Mardirosian"'
Publikováno v:
The FASEB Journal. 29
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b591d9734dee5cd8e013e188bc89c71a
https://doi.org/10.1096/fasebj.29.1_supplement.1013.6
https://doi.org/10.1096/fasebj.29.1_supplement.1013.6
Autor:
Francis J. Golder, D. MacIntyre, Courtney Ideo, Saro Mardirosian, Santhosh M. Baby, Sean Peng
Publikováno v:
The FASEB Journal. 28
OIRD may result, at least in part, from decreased CO2 chemosensitivity. Previously, we reported that GAL-021 administered IV reverses OIRD and increases CO2 chemosensitivity in rats. GAL-021 IV has...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f19146e0fad2b050d6a05353b4a7b72d
https://doi.org/10.1096/fasebj.28.1_supplement.1092.14
https://doi.org/10.1096/fasebj.28.1_supplement.1092.14
Autor:
Saro Mardirosian, Sean Peng, Veljko Puskovic, Courtney Ideo, D. MacIntyre, Francis J. Golder, Ryan B. Gruber, Matthew M. Hewitt
Publikováno v:
The FASEB Journal. 28
GAL-160 is a novel chemoreceptor modulator entering early clinical development as a therapeutic for sleep-disordered breathing. Here, we describe GAL-160’s properties as a ventilatory stimulant in ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d6d269e6f427b0554f14823cdfa36949
https://doi.org/10.1096/fasebj.28.1_supplement.873.3
https://doi.org/10.1096/fasebj.28.1_supplement.873.3